Hetz C, Silva-Aguero J, Ellerby L
eGastroenterology. 2025; 2(4):e100129.
PMID: 39944266
PMC: 11770430.
DOI: 10.1136/egastro-2024-100129.
Zhao K, Zhang H, Ding W, Yu X, Hou Y, Liu X
Hepatol Commun. 2025; 9(2).
PMID: 39878681
PMC: 11781772.
DOI: 10.1097/HC9.0000000000000639.
Mullin S, Kelly A, Ni Chathail M, Norris S, Shannon C, Roche H
Adv Nutr. 2025; 16(3):100375.
PMID: 39842721
PMC: 11849631.
DOI: 10.1016/j.advnut.2025.100375.
Barton B, Son F, Verma A, Bal S, Tang Q, Wang R
Nat Immunol. 2025; 26(2):200-214.
PMID: 39789376
DOI: 10.1038/s41590-024-02063-w.
Xu X, Mendoza A, Krumm C, Su S, Acuna M, Bare C
Sci Signal. 2024; 17(865):eadk7971.
PMID: 39626011
PMC: 11817722.
DOI: 10.1126/scisignal.adk7971.
MIST1 regulates endoplasmic reticulum stress-induced hepatic apoptosis as a candidate marker of fatty liver disease progression.
Hur S, Jeong H, Kim K, Kim K, Kim S, Lee Y
Cell Death Dis. 2024; 15(11):805.
PMID: 39516480
PMC: 11549289.
DOI: 10.1038/s41419-024-07217-0.
Transgelin 2 guards T cell lipid metabolism and antitumour function.
Hwang S, Awasthi D, Jeong J, Sandoval T, Chae C, Ramos Y
Nature. 2024; 635(8040):1010-1018.
PMID: 39443795
DOI: 10.1038/s41586-024-08071-y.
Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism.
Park S, Fadhul T, Conroy L, Clarke H, Sun R, Wallenius K
JCI Insight. 2024; 9(23).
PMID: 39418102
PMC: 11623947.
DOI: 10.1172/jci.insight.184396.
Roles of X-box binding protein 1 in liver pathogenesis.
Tak J, Kim Y, Kim S
Clin Mol Hepatol. 2024; 31(1):1-31.
PMID: 39355873
PMC: 11791611.
DOI: 10.3350/cmh.2024.0441.
Endoplasmic reticulum stress induces hepatic steatosis through interaction between PPARα and FoxO6 in vivo and in vitro.
Kim D
J Mol Med (Berl). 2024; 102(10):1267-1284.
PMID: 39198274
PMC: 11416408.
DOI: 10.1007/s00109-024-02480-2.
Endoplasmic reticulum stress in diseases.
Liu Y, Xu C, Gu R, Han R, Li Z, Xu X
MedComm (2020). 2024; 5(9):e701.
PMID: 39188936
PMC: 11345536.
DOI: 10.1002/mco2.701.
The PPIase Activity of CypB Is Essential for the Activation of Both AKT/mTOR and XBP1s Signaling Pathways during the Differentiation of 3T3-L1 Preadipocytes.
Kim G, Yoon K, Ha J, Kang I, Choe W
Nutrients. 2024; 16(15).
PMID: 39125345
PMC: 11313753.
DOI: 10.3390/nu16152465.
siRNA-loaded folic acid-modified TPGS alleviate MASH targeting ER stress sensor XBP1 and reprogramming macrophages.
Zhu M, Cheng Y, Zuo L, Bin B, Shen H, Meng T
Int J Biol Sci. 2024; 20(10):3823-3841.
PMID: 39113706
PMC: 11302883.
DOI: 10.7150/ijbs.96113.
Medaka liver developed Human NAFLD-NASH transcriptional signatures in response to ancestral bisphenol A exposure.
Chakraborty S, Anand S, Bhandari R
Res Sq. 2024; .
PMID: 39070641
PMC: 11275980.
DOI: 10.21203/rs.3.rs-4585175/v1.
Environmental monobutyl phthalate exposure promotes liver cancer via reprogrammed cholesterol metabolism and activation of the IRE1α-XBP1s pathway.
Zhang T, Zhao F, Hu Y, Wei J, Cui F, Lin Y
Oncogene. 2024; 43(30):2355-2370.
PMID: 38879588
DOI: 10.1038/s41388-024-03086-1.
Xbp1 targets canonical UPR and non-canonical pathways in separate tissues to promote longevity.
Li M, Shou H, Martinez Corrales G, Svermova T, Franco A, Alic N
iScience. 2024; 27(6):109962.
PMID: 38832022
PMC: 11144730.
DOI: 10.1016/j.isci.2024.109962.
Sex-specific expression of the human NAFLD-NASH transcriptional signatures in the liver of medaka with a history of ancestral bisphenol A exposure.
Chakraborty S, Anand S, Bhandari R
bioRxiv. 2024; .
PMID: 38826193
PMC: 11142124.
DOI: 10.1101/2024.05.19.594843.
Endoplasmic reticulum stress: bridging inflammation and obesity-associated adipose tissue.
Ma K, Zhang Y, Zhao J, Zhou L, Li M
Front Immunol. 2024; 15:1381227.
PMID: 38638434
PMC: 11024263.
DOI: 10.3389/fimmu.2024.1381227.
Exploring the IRE1 interactome: From canonical signaling functions to unexpected roles.
Le Goupil S, Laprade H, Aubry M, Chevet E
J Biol Chem. 2024; 300(4):107169.
PMID: 38494075
PMC: 11007444.
DOI: 10.1016/j.jbc.2024.107169.
Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets.
Mahmoudi A, Jalili A, Butler A, Aghaee-Bakhtiari S, Jamialahmadi T, Sahebkar A
J Clin Exp Hepatol. 2024; 14(4):101365.
PMID: 38433957
PMC: 10904918.
DOI: 10.1016/j.jceh.2024.101365.